0      0

2020 Annual Meeting


AM20-09 - AM20-09: From ABO Blood Group Determination to Immune Tolerance Induction: What Is the Role of the Human Gut Microbiome?


Oct 3, 2020 2:30pm ‐ Oct 3, 2020 3:30pm


Credits: None available.

Standard: $25.00
Members: $20.00

Description

Presented in collaboration with Be The Match BioTherapies®

The session will review the current understanding of the role of the intestinal microbiota in modeling the ABO phenotype and some important immune functions. Microorganisms from the gut flora may produce enzymes such as glycosidases that cleave the A and B antigens which could be applied to convert to type O blood. Gut microflora may also have important function in modulating the immune system and determine patient outcome during organ and cell transplantation rejection and/or graft versus host disease.

Learning Objectives:
  • Review current graft engineering strategies to promote immune tolerance following hematopoietic stem cell transplantation
  • Review the latest developments on the understanding of the role of the intestinal microbiome in immune tolerance induction
  • Review the latest research development in the role of the diversity of intestinal microbiome in preventing graft versus host disease following hematopoietic stem cell transplantation

Speaker(s):

Credits Available


AM20-09: From ABO Blood Group Determination to Immune Tolerance Induction: What Is the Role of the Human Gut Microbiome? Evaluation

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content